BCL2 and neoplasm: The divergent IL-6 responses observed here further reflect the influence of the miRNA-regulated PTEN and BCL-2 pathways, as IL-6 upregulation in PC3 aligns with a more aggressive, PTEN-deficient context, whereas IL-6 downregulation in LNCaP is consistent with enhanced tumor-suppressive signaling driven by their miRNA profile.